U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Protein
Created
by admin
on Mon Mar 31 21:39:20 GMT 2025
Edited
by admin
on Mon Mar 31 21:39:20 GMT 2025
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG4
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
MO4K3GDN1I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EMIBETUZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
emibetuzumab [INN]
Preferred Name English
IMMUNOGLOBULIN G4, ANTI-(HUMAN HEPATOCYTE GROWTH FACTOR RECEPTOR) (HUMAN-MUS MUSCULUS MONOCLONAL LY2875358 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL LY2875358 .KAPPA.-CHAIN, DIMER
Common Name English
LY2875358
Code English
LA480
Code English
LA-480
Common Name English
LY-2875358
Code English
Emibetuzumab [WHO-DD]
Common Name English
C-8H241
Code English
EMIBETUZUMAB [USAN]
Common Name English
Code System Code Type Description
FDA UNII
MO4K3GDN1I
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
SMS_ID
100000170769
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
CAS
1365287-97-3
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
DRUG BANK
DB11849
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109517
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
ChEMBL
CHEMBL3301578
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
NCI_THESAURUS
C95732
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
USAN
AB-67
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
INN
9932
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
WIKIPEDIA
Emibetuzumab
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
EVMPD
SUB184908
Created by admin on Mon Mar 31 21:39:20 GMT 2025 , Edited by admin on Mon Mar 31 21:39:20 GMT 2025
PRIMARY
From To
1_22 1_96
1_142 1_198
1_256 1_316
1_362 1_420
2_22 2_96
2_142 2_198
2_256 2_316
2_362 2_420
3_23 3_89
3_135 3_195
4_23 4_89
4_135 4_195
1_129 3_215
2_129 4_215
1_221 2_221
1_224 2_224
Glycosylation Link Type Site
N 1_292
N 2_292
Related Record Type Details
HEPATOCYTE GROWTH FACTOR RECEPTOR
TARGET -> INHIBITOR
Related Record Type Details
EMIBETUZUMAB
ACTIVE MOIETY

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
amino acid substitution [1_1] [2_1] Gln PIDOLIC ACID SZB83O1W42
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966